Optimum Strategic Communications
@optimumcomms.bsky.social
International Strategic Healthcare Communications. For further information contact@optimumcomms.com
Dermatology used to be thought of as a niche area. But our deeper understanding of what causes many skin diseases, has led to an explosion of interest. In our latest episode of #OptimumTV, Thibaud Portal and Brian Kim of Alys Pharmaceuticals explore what advances the company is making in the sector.
Why the immuno-dermatology space is heating up
YouTube video by Optimum Strategic Communications
www.youtube.com
June 19, 2025 at 10:35 AM
Dermatology used to be thought of as a niche area. But our deeper understanding of what causes many skin diseases, has led to an explosion of interest. In our latest episode of #OptimumTV, Thibaud Portal and Brian Kim of Alys Pharmaceuticals explore what advances the company is making in the sector.
Old names for diseases can date – either because of our growing scientific understanding of what’s really going on, or because they can end up ‘victim blaming’ patients. But renaming them has its own problems – such as lack of recognition. Read #Optimum’s latest #HotTopic on the conundrum here ⬇️
Hot topic: Should we keep renaming diseases? – Optimum Strategic CommunicationsLink to: Rewind Therapeutics Strengthens Scientific Advisory Board with Leading International Neurology Experts as it Adv...
www.optimumcomms.com
June 18, 2025 at 9:39 AM
Old names for diseases can date – either because of our growing scientific understanding of what’s really going on, or because they can end up ‘victim blaming’ patients. But renaming them has its own problems – such as lack of recognition. Read #Optimum’s latest #HotTopic on the conundrum here ⬇️
📺The last 18 months have seen an explosion of interest in Chinese biotechs, #OptimumTV spoke to Lan Zhang, CEO of Crimson Gateway, whose deep local knowledge provides a helping hand for those looking to go “shopping” in China, as well as incubating early-stage biotechs itself.
Crimson Gateway: Opening up China’s new world of biotech companies
YouTube video by Optimum Strategic Communications
www.youtube.com
June 16, 2025 at 10:28 AM
📺The last 18 months have seen an explosion of interest in Chinese biotechs, #OptimumTV spoke to Lan Zhang, CEO of Crimson Gateway, whose deep local knowledge provides a helping hand for those looking to go “shopping” in China, as well as incubating early-stage biotechs itself.
It has been another dynamic week for Optimum’s clients with SpliceBio’s successful $135m Series B financing, AMSilk venturing into consumer care, Alys Pharmaceuticals’ CTA submission and the first of Sofinnova Partners’ portfolio companies accessing revolutionary #AI technology. Subscribe today ⬇️
Weekly roundup: Innovation and deals for Optimum’s clients – Optimum Strategic CommunicationsLink to: Sofinnova Partners collaborates with NVIDIA to accelerate European life sciences startupsScroll to...
www.optimumcomms.com
June 13, 2025 at 10:24 AM
It has been another dynamic week for Optimum’s clients with SpliceBio’s successful $135m Series B financing, AMSilk venturing into consumer care, Alys Pharmaceuticals’ CTA submission and the first of Sofinnova Partners’ portfolio companies accessing revolutionary #AI technology. Subscribe today ⬇️
📺Rescuing biotech’s fallen angels? In the latest episode of #OptimumTV, Nick Bastin sat down with #Alis Biosciences Founder and Board Member Nicholas Johnston to find out more about the firm’s innovative approach to returning this trapped capital to investors and resuscitating viable science.
How to free up tens of billions trapped in the wrong place
YouTube video by Optimum Strategic Communications
www.youtube.com
June 12, 2025 at 9:50 AM
📺Rescuing biotech’s fallen angels? In the latest episode of #OptimumTV, Nick Bastin sat down with #Alis Biosciences Founder and Board Member Nicholas Johnston to find out more about the firm’s innovative approach to returning this trapped capital to investors and resuscitating viable science.
Science is making amazing advances as delegates at ASCO 2025 recently witnessed. But there is also a great deal of scepticism about evidence-based treatments in the world at large – a problem getting worse due to misinformation on social media. Read #Optimum’s latest #HotTopic here ⬇️
Hot topic: Science in the time of TikTok – Optimum Strategic CommunicationsLink to: SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pip...
www.optimumcomms.com
June 11, 2025 at 10:06 AM
Science is making amazing advances as delegates at ASCO 2025 recently witnessed. But there is also a great deal of scepticism about evidence-based treatments in the world at large – a problem getting worse due to misinformation on social media. Read #Optimum’s latest #HotTopic here ⬇️
Will we see you there? ON Helix is a great event which addresses key bio-innovation trends, generating discussions around the progress and future of the #LifeScience industry.
Optimum is a proud supporter of One Nucleus events, reach out if you would like to connect!
Optimum is a proud supporter of One Nucleus events, reach out if you would like to connect!
June 9, 2025 at 3:54 PM
Will we see you there? ON Helix is a great event which addresses key bio-innovation trends, generating discussions around the progress and future of the #LifeScience industry.
Optimum is a proud supporter of One Nucleus events, reach out if you would like to connect!
Optimum is a proud supporter of One Nucleus events, reach out if you would like to connect!
Its been a busy week in the industry from Amber Implants announcing the results of its 1yr follow-up data for VCFix to appointments with iOnctura bolstering its leadership team, and Asgard Therapeutics and Commit Biologics strengthening their advisory boards #OptimumNewsletter ⬇️
Weekly roundup: June kickstarts with an abundance of appointments – Optimum Strategic CommunicationsLink to: Commit Biologics appoints leading industry experts to newly formed Scientific Advisory Boar...
www.optimumcomms.com
June 6, 2025 at 12:08 PM
Its been a busy week in the industry from Amber Implants announcing the results of its 1yr follow-up data for VCFix to appointments with iOnctura bolstering its leadership team, and Asgard Therapeutics and Commit Biologics strengthening their advisory boards #OptimumNewsletter ⬇️
📺What options are there for life science companies to raise funds while there’s little appetite for IPOs? Marten Steen, Managing Partner at leading VC HealthCap, considers the possibilities in the latest #OptimumTV – although he predicts the situation will improve over the next 12 to 18 months.
Optimum Dealmakers: “No IPO? No problem.” Financing options during today’s IPO drought
YouTube video by Optimum Strategic Communications
www.youtube.com
June 5, 2025 at 10:01 AM
📺What options are there for life science companies to raise funds while there’s little appetite for IPOs? Marten Steen, Managing Partner at leading VC HealthCap, considers the possibilities in the latest #OptimumTV – although he predicts the situation will improve over the next 12 to 18 months.
It has been another great week for Optimum clients with Poolbeg being granted US FDA Orphan Drug Designation and Nucleome and STORM’s fantastic appointments. Subscribe to our weekly round-up to never miss an edition!
#OptimumNewsletter #HealthcareCommunications
#OptimumNewsletter #HealthcareCommunications
Weekly roundup: Success for Optimum clients in and out of the clinic – Optimum Strategic CommunicationsLink to: Bionical Emas and Pharma Resources Announce Exclusive Global Clinical Trial Supply Partn...
www.optimumcomms.com
May 30, 2025 at 1:33 PM
It has been another great week for Optimum clients with Poolbeg being granted US FDA Orphan Drug Designation and Nucleome and STORM’s fantastic appointments. Subscribe to our weekly round-up to never miss an edition!
#OptimumNewsletter #HealthcareCommunications
#OptimumNewsletter #HealthcareCommunications
#Biotech isn’t having the easiest time right now. But hard times, just like good times, don’t last forever, a subject our latest Hot Topic delves into. Read it here 👇
www.optimumcomms.com/hot-topic-bi...
www.optimumcomms.com/hot-topic-bi...
May 27, 2025 at 12:21 PM
#Biotech isn’t having the easiest time right now. But hard times, just like good times, don’t last forever, a subject our latest Hot Topic delves into. Read it here 👇
www.optimumcomms.com/hot-topic-bi...
www.optimumcomms.com/hot-topic-bi...
From Poolbeg Pharma’s successful £4.865 million fundraising, to the deepening of Novo Nordisk Foundation’s partnership with WHO, it has been a week that has shown resilience despite turbulent market conditions. Subscribe to our newsletter to ensure you never miss an edition ⬇️
#OptimumNewsletter
#OptimumNewsletter
Weekly roundup: A week of deals for Optimum clients despite turbulent markets – Optimum Strategic CommunicationsLink to: The must attend healthcare conference in Summer/Winter 2025Scroll to top
www.optimumcomms.com
May 23, 2025 at 1:35 PM
From Poolbeg Pharma’s successful £4.865 million fundraising, to the deepening of Novo Nordisk Foundation’s partnership with WHO, it has been a week that has shown resilience despite turbulent market conditions. Subscribe to our newsletter to ensure you never miss an edition ⬇️
#OptimumNewsletter
#OptimumNewsletter
Obesity drugs have largely been considered as nothing but a boon for pharma so far. But if they prove effective at cutting the risk of a range of serious diseases including cardiovascular and cancer, might they take a chunk out of other drugs’ revenues and profits? Read our latest hot topic ⬇️
Hot topic: Could obesity medicines gobble up other drugs’ profits? – Optimum Strategic CommunicationsLink to: Poolbeg Pharma plc – Proposed Retail Offer to raise up to £100,000Scroll to top
www.optimumcomms.com
May 20, 2025 at 1:46 PM
Obesity drugs have largely been considered as nothing but a boon for pharma so far. But if they prove effective at cutting the risk of a range of serious diseases including cardiovascular and cancer, might they take a chunk out of other drugs’ revenues and profits? Read our latest hot topic ⬇️
📺As a biotech CEO, how do you raise funds when the market doesn’t seem interested? Watch former Ablynx CEO Edwin Moses talk to Optimum TV about the attributes needed to succeed – and why he’s still actively involved in the industry as a non-executive chair of several life science companies.
Optimum Dealmakers: How to make your own luck
YouTube video by Optimum Strategic Communications
www.youtube.com
May 16, 2025 at 3:29 PM
📺As a biotech CEO, how do you raise funds when the market doesn’t seem interested? Watch former Ablynx CEO Edwin Moses talk to Optimum TV about the attributes needed to succeed – and why he’s still actively involved in the industry as a non-executive chair of several life science companies.
Summer is fast approaching and it is now less than five months until Optimum's 17th Annual Healthcare Conference! This prestigious invitation only event brings together investors and executives from across the life sciences sector, register your interest today: www.optimumcomms.com/irconference...
May 15, 2025 at 3:42 PM
Summer is fast approaching and it is now less than five months until Optimum's 17th Annual Healthcare Conference! This prestigious invitation only event brings together investors and executives from across the life sciences sector, register your interest today: www.optimumcomms.com/irconference...
From Alchemab’s landmark $415m licensing agreement with Eli Lilly & Co to clinical milestones from iOnctura and Vesper Bio, Optimum’s clients have had a busy week! Never miss industry news and subscribe today ⬇️
#OptimumsNewsletter #HealthcareCommunications
#OptimumsNewsletter #HealthcareCommunications
Weekly roundup: A multi-million dollar deal with Lilly and industry advances – Optimum Strategic CommunicationsLink to: Vesper Bio achieves enrolment milestone in Phase Ib/IIa trial of lead candidate ...
www.optimumcomms.com
May 9, 2025 at 1:27 PM
From Alchemab’s landmark $415m licensing agreement with Eli Lilly & Co to clinical milestones from iOnctura and Vesper Bio, Optimum’s clients have had a busy week! Never miss industry news and subscribe today ⬇️
#OptimumsNewsletter #HealthcareCommunications
#OptimumsNewsletter #HealthcareCommunications
The 1 week countdown to #BioEquityEurope is on!
Celebrating 25 years of this prestigious event, Optimum is proud to be sponsoring the networking breakfast.
Please reach out if you would like to connect with our CEO, Mary Clark and Associate Director, Zoe Bolt at the conference.
Celebrating 25 years of this prestigious event, Optimum is proud to be sponsoring the networking breakfast.
Please reach out if you would like to connect with our CEO, Mary Clark and Associate Director, Zoe Bolt at the conference.
May 6, 2025 at 3:23 PM
The 1 week countdown to #BioEquityEurope is on!
Celebrating 25 years of this prestigious event, Optimum is proud to be sponsoring the networking breakfast.
Please reach out if you would like to connect with our CEO, Mary Clark and Associate Director, Zoe Bolt at the conference.
Celebrating 25 years of this prestigious event, Optimum is proud to be sponsoring the networking breakfast.
Please reach out if you would like to connect with our CEO, Mary Clark and Associate Director, Zoe Bolt at the conference.
📺Most people have heard of Huntington’s disease - but not all really know what it is. To mark Huntington’s Disease Awareness Month, David Reynolds, CEO of LoQus23 Therapeutics, talked to #OptimumTV about its genetic underpinning, how it develops over time, symptoms, and modern treatment approaches.
What is Huntington’s disease - and how are treatment approaches changing?
YouTube video by Optimum Strategic Communications
www.youtube.com
May 6, 2025 at 9:55 AM
📺Most people have heard of Huntington’s disease - but not all really know what it is. To mark Huntington’s Disease Awareness Month, David Reynolds, CEO of LoQus23 Therapeutics, talked to #OptimumTV about its genetic underpinning, how it develops over time, symptoms, and modern treatment approaches.
Things are heating up in the life sciences industry with the exciting launch of blood cancer focused Cycuria Therapeutics, Novo Nordisk Foundation’s expansion of its Challenge Programme outside of Denmark for the first time, and Optimum clients featuring on The Medicine Maker Power List 2025! ⬇️
Weekly roundup: Another busy week in biopharma – Optimum Strategic CommunicationsLink to: Hot topic: Pandemics and the price of eggsScroll to top
www.optimumcomms.com
May 2, 2025 at 2:20 PM
Things are heating up in the life sciences industry with the exciting launch of blood cancer focused Cycuria Therapeutics, Novo Nordisk Foundation’s expansion of its Challenge Programme outside of Denmark for the first time, and Optimum clients featuring on The Medicine Maker Power List 2025! ⬇️
What does the price of eggs have to do with pandemics? On the face of it, not a lot. But in our new Hot Topic we discuss how a rampant bird flu outbreak in the US is impacting egg prices there – and, much more worryingly, getting virologists concerned about a fresh pandemic. Read it here ⬇️
Hot topic: Pandemics and the price of eggs – Optimum Strategic CommunicationsLink to: Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025Scroll to top
www.optimumcomms.com
April 30, 2025 at 3:34 PM
What does the price of eggs have to do with pandemics? On the face of it, not a lot. But in our new Hot Topic we discuss how a rampant bird flu outbreak in the US is impacting egg prices there – and, much more worryingly, getting virologists concerned about a fresh pandemic. Read it here ⬇️
It’s been an exciting week from the appointment of Renée Aguiar-Lucander as CEO of Hansa Biopharma, to the launch of Alis Biosciences - a fund aiming to free $30bn of trapped biotech capital, to a new edition of #OptimumTV’s Dealmakers series. Read the latest industry news below ⬇️
Weekly round-up: A fund aiming to free a whopping $30bn of trapped biotech capital, strategic hires, plus a new episode of ‘Dealmakers’ on Optimum TV – Optimum Strategic CommunicationsLink to: Novo Ho...
www.optimumcomms.com
April 25, 2025 at 3:41 PM
It’s been an exciting week from the appointment of Renée Aguiar-Lucander as CEO of Hansa Biopharma, to the launch of Alis Biosciences - a fund aiming to free $30bn of trapped biotech capital, to a new edition of #OptimumTV’s Dealmakers series. Read the latest industry news below ⬇️
📺 In the latest episode of #OptimumTV’s Dealmakers series, watch Jonathan Tobin of Brandon Capital talk about Trump, the threat of #tariffs, and why things are likely to have settled down by this time next year. Watch the full episode below!
#HealthcareCommunications
#HealthcareCommunications
Dealmakers: How Australasia’s leading life science-focused VC is spreading its wings in Europe & US
YouTube video by Optimum Strategic Communications
www.youtube.com
April 24, 2025 at 9:53 AM
📺 In the latest episode of #OptimumTV’s Dealmakers series, watch Jonathan Tobin of Brandon Capital talk about Trump, the threat of #tariffs, and why things are likely to have settled down by this time next year. Watch the full episode below!
#HealthcareCommunications
#HealthcareCommunications
Vaccine scepticism has grown in recent years and consequently the immediate outlook for research and development is somewhat clouded. On the eve of #WorldImmunizationWeek, our Hot Topic looks at their huge contribution to global health and the great strides being made in vaccine technology today ⬇️
Hot topic: What does the future hold for vaccines? – Optimum Strategic CommunicationsLink to: Alis Biosciences launches fund to free over USD$30 billion of capital trapped in listed development-stage ...
www.optimumcomms.com
April 23, 2025 at 4:06 PM
Vaccine scepticism has grown in recent years and consequently the immediate outlook for research and development is somewhat clouded. On the eve of #WorldImmunizationWeek, our Hot Topic looks at their huge contribution to global health and the great strides being made in vaccine technology today ⬇️
The last fortnight has certainly been a rollercoaster… Read this week’s Hot Topic on the possible impacts of #TrumpTarrifs ⬇️
#HealthcareCommunications #AI #OptimumsHotTopic
www.optimumcomms.com/will-trump-h...
#HealthcareCommunications #AI #OptimumsHotTopic
www.optimumcomms.com/will-trump-h...
April 17, 2025 at 11:26 AM
The last fortnight has certainly been a rollercoaster… Read this week’s Hot Topic on the possible impacts of #TrumpTarrifs ⬇️
#HealthcareCommunications #AI #OptimumsHotTopic
www.optimumcomms.com/will-trump-h...
#HealthcareCommunications #AI #OptimumsHotTopic
www.optimumcomms.com/will-trump-h...
It is less than a month to go until the Optimum Team is in Bruges for the 25th anniversary edition of #BioEquityEurope!
Optimum is proud to be sponsoring the networking breakfast at this prestigious event.
Please reach out if you would like to connect with us there!
#HealthcareCommunications
Optimum is proud to be sponsoring the networking breakfast at this prestigious event.
Please reach out if you would like to connect with us there!
#HealthcareCommunications
April 15, 2025 at 10:54 AM
It is less than a month to go until the Optimum Team is in Bruges for the 25th anniversary edition of #BioEquityEurope!
Optimum is proud to be sponsoring the networking breakfast at this prestigious event.
Please reach out if you would like to connect with us there!
#HealthcareCommunications
Optimum is proud to be sponsoring the networking breakfast at this prestigious event.
Please reach out if you would like to connect with us there!
#HealthcareCommunications